Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ2 | O43526 | 8/20 | 0.60 |
| ▸ | KCNQ3 | O43525 | 7/20 | 0.60 |
| ▸ | KCNQ4 | P56696 | 4/20 | 0.56 |
| ▸ | KCNQ5 | Q9NR82 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PDE5A | O76074 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PDE6D | O43924 | 1/20 | 0.44 |
| ▸ | PDE6A | P16499 | 1/20 | 0.44 |
| ▸ | PDE6G | P18545 | 1/20 | 0.44 |
| ▸ | PDE6B | P35913 | 1/20 | 0.44 |
| ▸ | PDE6C | P51160 | 1/20 | 0.44 |
| ▸ | PDE6H | Q13956 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3107079 | 1.00 | KCNQ2 (0.60) | KCNQ2KCNQ3KCNQ4KCNQ5TSHR | |
| SCHEMBL3109805 | 0.89 | KCNQ2 (0.62) | KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2 | |
| SCHEMBL30795662 | 0.89 | KCNQ2 (0.62) | KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2 | |
| SCHEMBL3100981 | 0.88 | KCNQ2 (0.64) | KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2 | |
| SCHEMBL30795702 | 0.88 | KCNQ2 (0.64) | KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2 | |
| SCHEMBL30795349 | 0.88 | KCNQ2 (0.69) | KCNQ2KCNQ3KCNQ4KCNQ5TSHR | |
| SCHEMBL3100552 | 0.88 | KCNQ2 (0.69) | KCNQ2KCNQ3KCNQ4KCNQ5TSHR | |
| SCHEMBL30794524 | 0.88 | MAPT (0.57) | KCNQ2KCNQ3KCNQ4KCNQ5TSHR | |
| SCHEMBL3100849 | 0.88 | MAPT (0.57) | KCNQ2KCNQ3KCNQ4KCNQ5TSHR | |
| SCHEMBL30795039 | 0.87 | KCNQ2 (0.68) | KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| EP-4580679-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | Biohaven Therapeutics Ltd. (VG) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024054807-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND TDP-43 MODULATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024050389-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-07 | — | — | WO | disclosed |